rethinkTHC Search
Menu
Study breakdown

CBD improved blood sugar, energy use, and bone density in menopausal mice while boosting gut bacteria

Animal StudyPreliminary evidence
The takeaway

Ovariectomized mice treated with CBD for 18 weeks showed improved glucose tolerance, increased energy expenditure, better bone density, and a bloom in beneficial Lactobacillus gut bacteria.

Postmenopausal women interested in CBD, researchers studying metabolic bone disease, and scientists investigating gut-bone health connections.

Improved bone density, glucose tolerance, and energy expenditure simultaneously

What the researchers found

CBD-treated ovariectomized mice had improved oral glucose tolerance, increased energy expenditure, and improved bone mineral density and bone microarchitecture. These improvements were accompanied by increased Lactobacillus abundance in the gut and gene expression changes consistent with reduced inflammation.

Why it matters

Postmenopausal women face increased risks of metabolic disease and osteoporosis with limited treatment options. If CBD can address multiple aspects of this risk profile while modifying the gut microbiome, it could offer a novel therapeutic approach.

The numbers in context

CBD dose: 25 mg/kg for 18 weeks. Improved whole body bone mineral density and content. Increased femoral bone volume fraction, trabecular thickness, and volumetric bone density. Increased Lactobacillus abundance. Gene expression changes indicated reduced inflammation and less bone resorption.

How the study worked

Ovariectomized (OVX) and sham surgery mice received CBD (25 mg/kg) or vehicle perorally for 18 weeks. Assessed glucose tolerance, energy expenditure, bone density (DXA and micro-CT), gut microbiome composition, and gene expression in intestine and femur.

What this study cannot tell us

Animal study in mice, so results may not translate to humans. Single CBD dose tested. The ovariectomy model approximates but does not fully replicate human menopause. Gut microbiome differences between mice and humans limit direct translation.

How to read the evidence

Preliminary: single animal study with one dose, no human data.

When this study was published

Published in 2022.

The bigger picture

The connection between CBD, gut microbiome, and bone health is a novel finding that bridges several active areas of research and could open new avenues for managing postmenopausal health.

Questions still open

  • Would these effects be seen in postmenopausal women? Is the gut microbiome change (Lactobacillus bloom) a mediator of the metabolic and bone benefits? What is the optimal CBD dose and duration for bone health?

Common questions

How did CBD affect bones?
CBD improved whole body bone mineral density and content, increased femoral bone volume and trabecular thickness, and shifted gene expression toward less bone breakdown (resorption).
What role did gut bacteria play?
CBD-treated mice had a significant increase in Lactobacillus species in the gut. These beneficial bacteria have been linked to improved metabolism and reduced inflammation, potentially mediating some of CBD's effects.
Could postmenopausal women benefit from CBD?
These preclinical results are promising, but human clinical trials are needed. The researchers explicitly call for further investigation of CBD as a therapeutic for postmenopause-related disorders.

Read the original research

Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus.

Frontiers in pharmacology, 13, 900667

Citation

Sui, Ke; Tveter, Kevin M; Bawagan, Fiona G; Buckendahl, Patricia; Martinez, Savannah A; Jaffri, Zehra H; MacDonell, Avery T; Wu, Yue; Duran, Rocio M; Shapses, Sue A; Roopchand, Diana E. (2022). Cannabidiol-Treated Ovariectomized Mice Show Improved Glucose, Energy, and Bone Metabolism With a Bloom in Lactobacillus.. Frontiers in pharmacology, 13, 900667. https://doi.org/10.3389/fphar.2022.900667

Explore the wider topic